| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
British Medical Bulletin 45:111-126 (1989)
© 1989 The British Council
research-article |
Diabetic neuropathy
Royal Hallamshire Hospital Sheffield, UK
Abstract
Many factors contribute to the nerve damage of diabetesmetabolic (myo-inositol), microvascular, glycosylations and ageing. The variety of clinical syndromes indicates the complexity of the disease. Measurement of peripheral and autonomic nerve function is improving allowing theestabliashment of prospoctive natural history and therapeutic studies. There is a need for standardization of clinical definition and staging.